In these conditions, chronic excess of glucocorticoid exposure leads to disruption of a multitude of bodily functions and contributes to disease processes such as insulin resistance and type 2 diabetes, obesity, cardiovascular disease, hypertension, osteoporosis, and mental health disorders[2]
Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin 4 in the lizard
Summary: Retatrutide does cause diarrhoea as a recognised side effect, confirmed in Phase 2 clinical trial data, with incidence increasing at higher doses and most episodes being mild to moderate in severity
Correct administration ensures optimal efficacy while minimizing potential side effects
While no specific diet is required, adopting healthy eating habits will maximise the benefits
The first clinical trials to explore this mechanism used the NPY-antagonist MK-0557